dc.contributor | Consorci Sanitari de Terrassa |
dc.contributor.author | Chatzikonstantinou, Thomas |
dc.contributor.author | Kapetanakis, Anargyros |
dc.contributor.author | Scarfo', Lydia |
dc.contributor.author | Allsup, David |
dc.contributor.author | Cabrero, Alejandro Alonso |
dc.contributor.author | Cuéllar-García, C. |
dc.contributor.author | KARAKATSOULIS, GEORGIOS |
dc.date.accessioned | 2023-09-22T10:57:45Z |
dc.date.available | 2023-09-22T10:57:45Z |
dc.date.issued | 2021-12 |
dc.identifier.citation | Chatzikonstantinou T, Karakatsoulis G, Scarfò L, Karakatsoulis G, Allsup D, Cabrero AA, et al. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study. Leukemia. 2021 Dec;35(12):3444-54. |
dc.identifier.uri | https://hdl.handle.net/11351/10343 |
dc.description | Leucèmia limfocítica crònica; Infeccions per coronavirus; Mortalitat |
dc.language.iso | eng |
dc.publisher | Springer Nature |
dc.relation.ispartofseries | Leukemia;35(12) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Leucèmia limfoide |
dc.subject | Mortalitat |
dc.subject | COVID-19 (Malaltia) |
dc.subject.mesh | Coronavirus Infections |
dc.subject.mesh | Leukemia, Lymphoid |
dc.subject.mesh | Mortality |
dc.title | COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41375-021-01450-8 |
dc.subject.decs | infecciones por Coronavirus |
dc.subject.decs | leucemia linfoide |
dc.subject.decs | mortalidad |
dc.relation.publishversion | https://doi.org/10.1038/s41375-021-01450-8 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.authoraffiliation | [Chatzikonstantinou T] Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece. Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. [Kapetanakis A] Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. [Scarfò L] Università Vita-Salute San Raffaele and IRCC Ospedale San Raffaele, Milan, Italy. [Karakatsoulis G] Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece. Department of Mathematics, University of Ioannina, Ioannina, Greece. [Allsup D] Centre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Hull, UK. [Cabrero AA] Spanish Society of Haematology and hemotherapy, Madrid, Spain. Hematology Department, Hospital Universitario de La Princesa, Madrid, Spain. [Cuéllar-García C] Unitat d'Hematologia, Hospital de Terrassa, Consorci Sanitari de Terrassa, Terrassa, Spain |
dc.identifier.pmid | 34725454 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |